Federated Hermes, Inc. Ligand Pharmaceuticals Inc Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$68.64 - $89.2 $497,640 - $646,700	-7,250 Reduced 18.61%	31,714 $2.32 Million
Q4 2023 Jan 31, 2024	SELL	$49.57 - $72.63 $498,674 - $730,657	-10,060 Reduced 20.52%	38,964 $2.78 Million
Q3 2023 Nov 13, 2023	SELL	$58.86 - $72.67 $14,420 - $17,804	-245 Reduced 0.5%	49,024 $2.94 Million
Q2 2023 Aug 14, 2023	SELL	$69.53 - $79.33 $136,209 - $155,407	-1,959 Reduced 3.82%	49,269 $3.55 Million
Q1 2023 May 08, 2023	BUY	$65.67 - $77.08 $1.55 Million - $1.82 Million	23,661 Added 85.83%	51,228 $3.77 Million
Q4 2022 Feb 13, 2023	BUY	$61.72 - $96.74 $1.7 Million - $2.67 Million	27,556 Added 250509.09%	27,567 $1.84 Million
Q2 2022 Aug 15, 2022	SELL	$74.52 - $117.06 $509,418 - $800,222	-6,836 Reduced 99.84%	11 $1,000
Q1 2022 May 13, 2022	SELL	$94.99 - $151.56 $222,846 - $355,559	-2,346 Reduced 25.52%	6,847 $770,000
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $383 - $497	-3 Reduced 0.03%	9,193 $1.42 Million
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $5.75 Million - $8.13 Million	-56,181 Reduced 85.93%	9,196 $1.28 Million
Q2 2021 Aug 16, 2021	BUY	$113.03 - $155.64 $5.92 Million - $8.15 Million	52,377 Added 402.9%	65,377 $8.58 Million
Q1 2021 May 13, 2021	SELL	$99.52 - $215.83 $2.31 Million - $5 Million	-23,173 Reduced 64.06%	13,000 $1.98 Million
Q4 2020 Feb 12, 2021	BUY	$80.55 - $106.05 $1.03 Million - $1.36 Million	12,789 Added 54.69%	36,173 $3.6 Million
Q3 2020 Nov 12, 2020	BUY	$89.56 - $126.72 $1.9 Million - $2.69 Million	21,216 Added 978.6%	23,384 $2.23 Million
Q2 2020 Aug 13, 2020	SELL	$68.28 - $123.65 $614 - $1,112	-9 Reduced 0.41%	2,168 $242,000
Q1 2020 May 13, 2020	SELL	$63.37 - $107.88 $29,783 - $50,703	-470 Reduced 17.76%	2,177 $158,000
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $62,623 - $73,379	-646 Reduced 19.62%	2,647 $276,000
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $50,887 - $70,894	-590 Reduced 15.19%	3,293 $328,000
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $379,051 - $456,570	-3,530 Reduced 47.62%	3,883 $443,000
Q1 2019 May 10, 2019	BUY	$105.93 - $142.47 $22,880 - $30,773	216 Added 3.0%	7,413 $932,000
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $2.72 Million - $5.78 Million	-21,226 Reduced 74.68%	7,197 $976,000
Q3 2018 Nov 13, 2018	SELL	$211.18 - $274.49 $7.86 Million - $10.2 Million	-37,216 Reduced 56.7%	28,423 $7.8 Million
Q2 2018 Aug 10, 2018	BUY	$150.77 - $207.98 $7.38 Million - $10.2 Million	48,953 Added 293.38%	65,639 $13.6 Million
Q1 2018 May 09, 2018	SELL	$138.63 - $182.62 $818,055 - $1.08 Million	-5,901 Reduced 26.13%	16,686 $2.76 Million
Q4 2017 Feb 14, 2018	BUY	$128.36 - $147.04 $1.07 Million - $1.22 Million	8,310 Added 58.21%	22,587 $0
Q3 2017 Nov 13, 2017	BUY	$120.91 - $137.94 $1.73 Million - $1.97 Million	14,277	14,277 $1.94 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account